Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Flexion Therapeutics Inc. FLXN

Healthcare Drug Manufacturers - Major
Flexion Therapeutics Inc is a United States-based specialty pharmaceutical company. The company focuses on the development and commercialization of novel, local therapies. The company specializes in the treatment of patients with musculoskeletal conditions beginning with osteoarthritis. The products offered by company are zilretta which is used for enhancing the clinical effect of intra... see more

Recent & Breaking News (NDAQ:FLXN)

Flexion Therapeutics Announces Preliminary Third-Quarter 2020 ZILRETTA® Net Sales of Approximately $23.6 Million

GlobeNewswire October 13, 2020

Flexion Therapeutics to Present at the 2020 Cell & Gene Virtual Meeting on the Mesa

GlobeNewswire October 8, 2020

Flexion Therapeutics Announces Podium Presentation of FX301 Preclinical Data at Virtual ANESTHESIOLOGY 2020 Meeting

GlobeNewswire October 5, 2020

Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 2, 2020

Flexion Therapeutics to Present at the H.C. Wainwright Virtual Healthcare Conference

GlobeNewswire September 9, 2020

Flexion Therapeutics Announces Treatment of First Patient in Second Cohort of FX201 Phase 1 Dose-Escalation Trial

GlobeNewswire September 8, 2020

Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire September 4, 2020

Flexion Therapeutics to Present at the Wells Fargo 2020 Virtual Healthcare Conference

GlobeNewswire September 3, 2020

Flexion Therapeutics Announces Appointment of Liz Kwo, MD, to its Board of Directors

GlobeNewswire August 19, 2020

Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire August 7, 2020

Flexion Therapeutics Reports Second-Quarter 2020 Financial Results and Recent Business Highlights

GlobeNewswire August 5, 2020

Flexion Therapeutics to Report Second-Quarter 2020 Financial Results on August 5, 2020

GlobeNewswire July 30, 2020

Flexion Therapeutics Announces Preliminary Second-Quarter 2020 ZILRETTA® Net Sales

GlobeNewswire July 14, 2020

Flexion Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

GlobeNewswire June 16, 2020

Flexion Therapeutics Announces Pricing of Public Offering of Common Stock

GlobeNewswire May 21, 2020

Flexion Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire May 20, 2020

Flexion Therapeutics to Present at the RBC Capital Markets 2020 Virtual Global Healthcare Conference

GlobeNewswire May 13, 2020

Flexion Therapeutics Reports First-Quarter 2020 Financial Results and Recent Business Highlights

GlobeNewswire May 7, 2020

Flexion Therapeutics Announces Virtual Poster Presentations for FX201, an Intra-Articular Gene Therapy Candidate for the Treatment of Osteoarthritis, at the American Society of Gene & Cell Therapy Annual Meeting

GlobeNewswire May 5, 2020

Flexion Therapeutics Announces Publication of New Abstracts Accepted at Osteoarthritis Research Society International OARSI 2020

GlobeNewswire May 1, 2020